A retrospective study of 1- versus 2-cm excision margins for cutaneous malignant melanomas thicker than 2 mm

J Am Acad Dermatol. 2015 Jun;72(6):1054-9. doi: 10.1016/j.jaad.2015.03.029. Epub 2015 Apr 13.

Abstract

Background: Most guidelines recommend at least 2-cm excision margin for melanomas thicker than 2 mm.

Objective: We evaluated whether 1- or 2-cm excision margins for melanoma (>2 mm) result in different outcomes.

Methods: This is a retrospective cohort study on patients with melanomas (>2 mm) who underwent tumor excision with 1-cm (228 patients) or 2-cm (97 patients) margins to investigate presence of local recurrences, locoregional and distant metastases, and disease-free and overall survival.

Results: In all, 325 patients with mean age of 61.84 years and Breslow thickness of 4.36 mm were considered for the study with a median follow-up of 1852 days (1995-2012). There was no significant difference in the frequency of locoregional and distant metastasis between the 2 groups (P = .311 and .571). The survival analysis showed no differences for disease-free (P = .800; hazard ratio 0.948; 95% confidence interval 0.627-1.433) and overall (P = .951; hazard ratio 1.018; 95% confidence interval 0.575-1.803) survival.

Limitations: The study was not prospectively randomized.

Conclusions: Our study did not show any significant differences in important outcome parameters such as local or distant metastases and overall survival. A prospective study testing 1- versus 2-cm excision margin is warranted.

Keywords: disease-free survival; margin of excision; melanomas thicker than 2 mm; metastases; overall survival; recurrences.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cohort Studies
  • Confidence Intervals
  • Databases, Factual
  • Dermatologic Surgical Procedures / methods*
  • Dermatologic Surgical Procedures / mortality
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Melanoma / mortality*
  • Melanoma / pathology
  • Melanoma / surgery*
  • Melanoma, Cutaneous Malignant
  • Middle Aged
  • Mohs Surgery / methods
  • Mohs Surgery / mortality
  • Neoplasm Invasiveness / pathology
  • Neoplasm Staging
  • Proportional Hazards Models
  • Retrospective Studies
  • Risk Assessment
  • Skin Neoplasms / mortality*
  • Skin Neoplasms / pathology
  • Skin Neoplasms / surgery*
  • Survival Analysis
  • Time Factors
  • Treatment Outcome